Dr. Nagourney's Blog

Email-box.png

Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

Recurrent BRCA Positive Ovarian Cancer: An Unexpected Opportunity
By Robert A. Nagourney, MD
For the over 22,000 women in the United States diagnosed each year with ovarian cancer outcomes have improved slowly, yet the majority of these women still do not survive five years. Despite these statistics, ovarian cancer remains one of the...
Stage 4 Uterine Cancer & BRCA Gene Mutation Story Gets Interesting
By Robert A. Nagourney, MD
  The discovery of the BRCA genes by Mary Claire King and Mark Skolnick in the 1990s provided immense insights. It explained...
BRCA Prostate Cancer: Lessons Learned from a Successful Outcome
By Robert A. Nagourney, MD
On March 29, 2016, we reported the story of a 55 year old man diagnosed 13 years earlier with prostate cancer who had failed...
Aggressive Prostate Cancer: A Life-Saving Opportunity Nearly Missed
By Robert A. Nagourney, MD
A 42 year old gentleman presented in 2003 with an aggressive prostate cancer. He underwent surgery, radiation, hormones,...
Triple Negative Breast Cancer - Worse or Just Different?
By Robert A. Nagourney, MD
The term “triple negative breast cancer” (TNBC) is applied to a subtype of breast cancers that do not express the estrogen or...
The Angelina Jolie Effect
By Robert A. Nagourney, MD
Angelina Jolie’s willingness to bravely publish her saga, as she confronts the risk of a nefarious form of cancer, has focused...
Can PARP Inhibitors be Tested Using the EVA-PCD Assay?
By Robert A. Nagourney, MD
Poly ADP ribose polymerase (PARP) is a nuclear enzyme associated with response to DNA damage. Following single strand DNA...

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.